SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CAPLIN POINT LABORATORIES

BSE: 524742 28 Jun 2025
Healthcare
₹ 2022
Caplin Point Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

CAPLIN POINT LABORATORIES - Share Price & Details

Market Cap
₹15,549
High /Low
2,641 / 1,365
Stock P/E
29.0
Book Value
₹375.0
Dividend Yield
0.24
ROCE
25.8
ROE
₹21.7
Face Value
2.0
PEG Ratio
1.41
EVEBITDA
₹20.1
Debt
5.02
CMP / FCF
94.9
Debt to equity
₹0.0
NP Ann
541
High price all time
2,641
Piotroski score
₹5.0
Graham Number
772.0
No. Eq. Shares
7.6
Net CF
₹59.3
Net profit
541
Price to book value
5.45
Interest Coverage
₹1,110
Low price all time
1.05
Industry PE
32.0
Reserves
₹2,835
Free Cash Flow
₹241

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
CAPLIN POINT LABORATORIES LTD.5281.91452.85024.518.6915,54929.0
Blue Jet Healthcare Limited3526.71100.953404.456.351501049.2
Rainbow Children's Medicare LiNANANANA1474762.1

Peer Comparison Chart


About CAPLIN POINT LABORATORIES

Caplin Point Laboratories Ltd., with Security Code 524742, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

(16 Jun 2025)
Most readers would already be aware that Caplin Point Laboratories' (NSE:CAPLIPOINT) stock increased significantly by...
Read more →

Caplin Point Laboratories - Bullish Momentum: 4 stocks with White Marubozu Pattern on June 11

(12 Jun 2025)
Close: Rs 2116.2| Change (%) 4.18 Caplin Point Laboratories.
Read more →

Caplin Point Laboratories Faces Mixed Performance Amid Shift to Bearish Trend

(06 Jun 2025)
Caplin Point Laboratories has recently experienced a change in its evaluation, indicating a shift in its technical trend. The company reported strong...
Read more →

CAPLIN POINT LABORATORIES ANNOUNCES ACQUISITION OF TRIWIN PHARMA S A DE C V

(05 Jun 2025)
Caplin Point Laboratories announced that the Company's wholly owned Subsidiary Caplin Point Far East, Hong Kong, had executed Share Purchase...
Read more →

Caplin Point arm executes share purchase agreement to acquire entire stake in Triwin Pharma

(04 Jun 2025)
Caplin Point Laboratories Ltd. on Wednesday, June 4, said its wholly-owned subsidiary Caplin Point Far East Ltd, Hong Kong,...
Read more →

Caplin Point Laboratories announces acquisition of Triwin Pharma S.A DE C.V

(04 Jun 2025)
Caplin Point Laboratories announced that the Company's wholly owned Subsidiary Caplin Point Far East, Hong Kong, had executed Share Purchase...
Read more →